Neovascular Glaucoma Research Papers - Academia.edu (original) (raw)

Introduction: Neovascular glaucoma (NVG) is an aggressive glaucoma subtype of difficult management. Cyclodestructive procedures are a viable treatment option and diode laser ablation has been reported to be effective and safe. The purpose... more

Introduction: Neovascular glaucoma (NVG) is an aggressive glaucoma subtype of difficult management. Cyclodestructive procedures are a viable treatment option and diode laser ablation has been reported to be effective and safe. The purpose of this study was to evaluate the effectiveness and safety profile of diode laser cyclophotocoagulation in diabetic NVG.
Methods: Ambispective case-control study of 38 eyes (19 control group CG, 19 treatment group TG). Success was defined as intra-ocular pressure (IOP) <22mmHg or a 30% reduction from baseline. Intraocular pressure, number of anti-glaucoma drugs, visual acuity and pain were documented.
Results. Both groups were similar in age, sex and initial IOP. Follow-up time was 11 months (TG) and 7 months (CG). Cyclophotocoagulation was carried out in 19 eyes of TG (100J/session). IOP decreased from 38.7mmHg to 13mmHg in TG (p<0.001), vs. 42.6mmHg to 47.3mmHg in the CG (p=0.23). Success was achieved in 73.6% of the TG. Only 5 eyes (X%) developed hypotony (<5mmHg) post-treatment.
Conclusion. Diode laser cyclophotocoagulation is an effective IOP lowering procedure in diabetic NVG. Laser treatment energy per session should be lowered to 40-80J in order to reduce the risk of ocular hypotony.

Purpose: To report the effectiveness of combined surgery for neovascular glaucoma. Methods: Six eyes of six consecutive patients with neovascular glaucoma underwent the combined surgery: trabeculectomy with Mitomycin C, Pars Plana... more

Purpose: To report the effectiveness of combined surgery for neovascular glaucoma. Methods: Six eyes of six consecutive patients with neovascular glaucoma underwent the combined surgery: trabeculectomy with Mitomycin C, Pars Plana Vitrectomy (PPV), endolaserpanretinal photocoagulation, intravitreal and intracameral injection of bevacizumab. Results: The intraocular pressure returned to normal range soon after operation. The neovascularization of iris regressed in a few days. Mild hyphema developed in three patients. All six patients had improved or stable visual acuity, and achieved normal intraocular pressure without antiglaucoma medications three months after operation. Conclusions: This combined surgery may break the vicious cycle of neovascularglaucoma and preserve useful vision in these patients.

The main goal in the struggle with neovascular glaucoma is to control intraocular pressure (IOP) and pain. 152 patients, e.g., 203 eyes, were examined at the Clinic of Ophthalmology, Clinical Centre of Kragujevac, Serbia, in period... more

The main goal in the struggle with neovascular glaucoma is to control intraocular pressure (IOP) and pain. 152 patients, e.g., 203 eyes, were examined at the Clinic of Ophthalmology, Clinical Centre of Kragujevac, Serbia, in period between 01. 01. 2005 - 31. 12. 2010. Cyclocryoanemisatio was performed for all patients. Measurments of IOP showed statistical significant changes before and after the treatment for every patients. There was no difference in sex distribution, but a difference was noted in age distribution. Early posttreatment complications included hyphema, fibrin's exudation, chemosis. Cyclocryotherapy is usefull and accessible method for control of intensive pain in neovascular glaucoma.